BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30210531)

  • 1. The Telomerase Complex Directly Controls Hematopoietic Stem Cell Differentiation and Senescence in an Induced Pluripotent Stem Cell Model of Telomeropathy.
    Jose SS; Tidu F; Burilova P; Kepak T; Bendickova K; Fric J
    Front Genet; 2018; 9():345. PubMed ID: 30210531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere dynamics and hematopoietic differentiation of human DKC1-mutant induced pluripotent stem cells.
    Donaires FS; Alves-Paiva RM; Gutierrez-Rodrigues F; da Silva FB; Tellechea MF; Moreira LF; Santana BA; Traina F; Dunbar CE; Winkler T; Calado RT
    Stem Cell Res; 2019 Oct; 40():101540. PubMed ID: 31479877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs.
    Winkler T; Hong SG; Decker JE; Morgan MJ; Wu C; Hughes WM; Yang Y; Wangsa D; Padilla-Nash HM; Ried T; Young NS; Dunbar CE; Calado RT
    J Clin Invest; 2013 May; 123(5):1952-63. PubMed ID: 23585473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibition.
    Stockklausner C; Raffel S; Klermund J; Bandapalli OR; Beier F; Brümmendorf TH; Bürger F; Sauer SW; Hoffmann GF; Lorenz H; Tagliaferri L; Nowak D; Hofmann WK; Buergermeister R; Kerber C; Rausch T; Korbel JO; Luke B; Trumpp A; Kulozik AE
    Aging (Albany NY); 2015 Nov; 7(11):911-27. PubMed ID: 26546739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomere restoration and extension of proliferative lifespan in dyskeratosis congenita fibroblasts.
    Westin ER; Chavez E; Lee KM; Gourronc FA; Riley S; Lansdorp PM; Goldman FD; Klingelhutz AJ
    Aging Cell; 2007 Jun; 6(3):383-94. PubMed ID: 17381549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HuR regulates telomerase activity through TERC methylation.
    Tang H; Wang H; Cheng X; Fan X; Yang F; Zhang M; Chen Y; Tian Y; Liu C; Shao D; Jiang B; Dou Y; Cong Y; Xing J; Zhang X; Yi X; Songyang Z; Ma W; Zhao Y; Wang X; Ma J; Gorospe M; Ju Z; Wang W
    Nat Commun; 2018 Jun; 9(1):2213. PubMed ID: 29880812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response.
    Westin ER; Khodadadi-Jamayran A; Pham LK; Tung ML; Goldman FD
    G3 (Bethesda); 2023 Nov; 13(11):. PubMed ID: 37717172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous telomerase deficiency in mouse and man: when less is definitely not more.
    Mason PJ; Bessler M
    Cell Cycle; 2004 Sep; 3(9):1127-9. PubMed ID: 15326392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of TERC haploinsufficiency on the inheritance of telomere length.
    Goldman F; Bouarich R; Kulkarni S; Freeman S; Du HY; Harrington L; Mason PJ; Londoño-Vallejo A; Bessler M
    Proc Natl Acad Sci U S A; 2005 Nov; 102(47):17119-24. PubMed ID: 16284252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.
    Raval A; Behbehani GK; Nguyen le XT; Thomas D; Kusler B; Garbuzov A; Ramunas J; Holbrook C; Park CY; Blau H; Nolan GP; Artandi SE; Mitchell BS
    PLoS One; 2015; 10(7):e0131722. PubMed ID: 26133370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis.
    Pignolo RJ; Suda RK; McMillan EA; Shen J; Lee SH; Choi Y; Wright AC; Johnson FB
    Aging Cell; 2008 Jan; 7(1):23-31. PubMed ID: 18028256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
    Babizhayev MA; Yegorov YE
    J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis.
    García-Castillo J; Alcaraz-Pérez F; Martínez-Balsalobre E; García-Moreno D; Rossmann MP; Fernández-Lajarín M; Bernabé-García M; Pérez-Oliva AB; Rodríguez-Cortez VC; Bueno C; Adatto I; Agarwal S; Menéndez P; Zon LI; Mulero V; Cayuela ML
    Proc Natl Acad Sci U S A; 2021 Aug; 118(32):. PubMed ID: 34353901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triallelic and epigenetic-like inheritance in human disorders of telomerase.
    Collopy LC; Walne AJ; Cardoso S; de la Fuente J; Mohamed M; Toriello H; Tamary H; Ling AJ; Lloyd T; Kassam R; Tummala H; Vulliamy TJ; Dokal I
    Blood; 2015 Jul; 126(2):176-84. PubMed ID: 26024875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow failure and the telomeropathies.
    Townsley DM; Dumitriu B; Young NS
    Blood; 2014 Oct; 124(18):2775-83. PubMed ID: 25237198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe growth defect in mouse cells lacking the telomerase RNA component.
    Niida H; Matsumoto T; Satoh H; Shiwa M; Tokutake Y; Furuichi Y; Shinkai Y
    Nat Genet; 1998 Jun; 19(2):203-6. PubMed ID: 9620783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced telomere rejuvenation in pluripotent cells reprogrammed via nuclear transfer relative to induced pluripotent stem cells.
    Le R; Kou Z; Jiang Y; Li M; Huang B; Liu W; Li H; Kou X; He W; Rudolph KL; Ju Z; Gao S
    Cell Stem Cell; 2014 Jan; 14(1):27-39. PubMed ID: 24268696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust DNA Damage Response and Elevated Reactive Oxygen Species in TINF2-Mutated Dyskeratosis Congenita Cells.
    Pereboeva L; Hubbard M; Goldman FD; Westin ER
    PLoS One; 2016; 11(2):e0148793. PubMed ID: 26859482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem Cells.
    Nagpal N; Wang J; Zeng J; Lo E; Moon DH; Luk K; Braun RO; Burroughs LM; Keel SB; Reilly C; Lindsley RC; Wolfe SA; Tai AK; Cahan P; Bauer DE; Fong YW; Agarwal S
    Cell Stem Cell; 2020 Jun; 26(6):896-909.e8. PubMed ID: 32320679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.